Macrophages‐Based Biohybrid Microrobots for Breast Cancer Photothermal Immunotherapy by Inducing Pyroptosis

Guozheng Xing,Xuya Yu,Yan Zhang,Shupei Sheng,Limin Jin,Dunwan Zhu,Lin Mei,Xia Dong,Feng Lv
DOI: https://doi.org/10.1002/smll.202305526
IF: 13.3
2023-10-06
Small
Abstract:Macrophages‐based microrobots are constructed with the fusion of macrophages and metal–organic frameworks to exert functions such as tumor‐targeted, fluorescent navigation, and photothermal conversion. Active tumor accumulation of microrobots is achieved for inherent tumor tropism. Photothermal‐enhanced tumor‐specific pyroptosis induces robust and adaptive immune response, achieving photothermal immunotherapy for breast tumor proliferation and lung metastasis. Pyroptosis‐based immunotherapy can escape drug resistance as well as inhibit metastasis. It is urgently required to develop a delivery platform to induce targeted tumor‐specific pyroptosis for cancer immunotherapy. Herein, macrophages‐based biohybrid microrobots (IDN@MC) are constructed with IR‐macrophage and decitabine‐loaded Metal‐organic frameworks (DZNPs). The integration of fluorescence photosensitizers and pH‐sensitive DZNPs endow the microrobots properties such as photothermal conversion, fluorescent navigation, targeted drug delivery, and controlled drug release. In light of the inherent tumor targeting, tumor accumulation of IDN@MC is facilitated. Due to the sustained release of decitabine from packaged DZNPs, the host macrophages are differentiated into M1 phenotypes to exert the tumor phagocytosis at the tumor site, directly transporting the therapeutic agents into cancer cells. With laser control, the rapid and durable caspase 3‐cleaved gasdermin E (GSDME)‐related tumor pyroptosis is achieved with combined photothermal‐chemotherapy, releasing inflammatory factors such as lactate dehydrogenase and interleukin‐18. Subsequently, the robust and adaptive immune response is primed with dendritic cell maturation to initiate T‐cell clone expansion and modulation of the immune suppressive microenvironment, thus enhancing the tumor immunotherapy to inhibit tumor proliferation and metastasis. This macrophages‐based biohybrid microrobot is an efficient strategy for breast cancer treatment to trigger photo‐induced pyroptosis and augment the immune response.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to effectively induce pyroptosis in breast cancer treatment, so as to enhance the immune response and inhibit the growth and metastasis of tumors. Specifically, the researchers constructed a macrophage - based bio - hybrid microrobot (IDN@MC). This microrobot can achieve photothermal immunotherapy for breast cancer cells through functions such as photothermal conversion, fluorescence - guided navigation, targeted drug delivery, and controlled drug release. Through laser control, these microrobots can release the chemotherapeutic drug decitabine (DAC) at the tumor site, induce macrophages to differentiate into M1 type, and then directly deliver the therapeutic agent into cancer cells, triggering pyroptosis under the photothermal - chemotherapy synergy. This process not only leads to the death of cancer cells, but also activates the systemic anti - tumor immune response by releasing inflammatory factors such as lactate dehydrogenase (LDH) and interleukin - 18 (IL - 18), thereby inhibiting the progression and metastasis of tumors. The key innovation points of the paper are: 1. **Design of multi - functional bio - hybrid microrobot**: Integrates multiple functions such as fluorescence - guided navigation, photothermal conversion, targeted drug delivery, and controlled release. 2. **Utilization of macrophages**: Utilizes the natural biological tropism and high drug - loading capacity of macrophages to achieve precise targeting of the tumor site. 3. **pH - sensitive metal - organic frameworks (MOFs)**: Used to encapsulate chemotherapeutic drugs, achieving continuous release under pH control, and improving the stability and targeting of drugs. 4. **Photothermal - chemotherapy synergy**: Through laser irradiation, local high temperature is achieved, promoting drug release and cancer cell pyroptosis, while activating the immune response. These innovation points together form an efficient breast cancer treatment platform and are expected to achieve better treatment results in the clinic.